BioPharmSignal logoBioPharmSignal

Biotech News

Materialise Reports Second Quarter and Half-Year 2026 Results

Materialise (MTLS)MaterialiseEarnings

Regulated information 1 LEUVEN, Belgium --(BUSINESS WIRE)--Aug. 27, 2026-- Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the second quarter

Related news

MTLSMaterialise2026-08-13 10:45 EST

Materialise NV to Report Second Quarter and Half-Year 2026 Earnings on Thursday, August 27, 2026

MTLSMaterialise2026-05-07 05:00 EST

Materialise Reports First Quarter 2026 Results

View all latest news

Materialise

Additive-Manufacturing Technology Materialise is a global 3D-printing company providing software, production services and medical applications. Its technology supports the design and manufacture of complex parts from digital models. Medical Solutions The medical segment develops patient-specific surgical planning tools, anatomical...

Recent company news

MTLSMaterialise2026-09-28 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

MTLSMaterialise2026-09-28 20:00 EST

MATERIALISE AANDELENINKOOPPROGRAMMA

MTLSMaterialise2026-09-21 20:00 EST

MATERIALISE AANDELENINKOOPPROGRAMMA

MTLSMaterialise2026-09-21 20:00 EST

MATERIALISE SHARE-BUY BACK PROGRAM

MTLSMaterialise2026-09-14 20:00 EST

MATERIALISE AANDELENINKOOPPROGRAMMA

Stock data

Close
8.50 USD
Market cap
401.4M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States